MSI2 and neoplasm: Although the high level of MSI2 has been linked to high-grade NSCLC and metastatic staging in patients [16, 17], which was validated in the present study (Fig. 1A–I), the expression of MSI2 and its functional role in TME stromal cells during tumor progression and metastasis have never been studied.